Home Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
Article Open Access

Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2

  • Hangzhou Tian , Geyu Chen , Sen Chen , Wenqiang Tang ORCID logo and Bin Liu ORCID logo EMAIL logo
Published/Copyright: September 30, 2024
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 239 Issue 6

Abstract

C19H14N2O2, monoclinic, P21/n (no. 14), a = 11.3111(5) Å, b = 7.2906(3) Å, c = 18.0875(10) Å, β = 102.935(2)°V = 1,453.73(12) Å3, Z = 4, Rgt (F) = 0.0545, wRref (F 2) = 0.1389, T = 150 K.

CCDC no.: 2337089

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.16 × 0.08 × 0.06 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.09 mm−1
Diffractometer, scan mode: Bruker D8 VENTURE, φ and ω
θ max, completeness: 26.0°, 99 %
N(hkl)measured, N(hkl)unique, R int: 10,087, 2,812, 0.085
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 1,853
N(param)refined: 209
Programs: Bruker 1 , SHELX 2 , 3 , Olex2 4
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso */U eq
C1 0.1410 (2) 0.6852 (3) 0.54911 (13) 0.0240 (6)
C2 0.0573 (2) 0.7632 (3) 0.48928 (14) 0.0309 (6)
H2 −0.022128 0.794584 0.494122 0.037*
C3 0.0942 (2) 0.7933 (3) 0.42256 (14) 0.0333 (7)
H3 0.039024 0.847512 0.380913 0.040*
C4 0.2103 (3) 0.7464 (3) 0.41453 (14) 0.0339 (7)
H4 0.232535 0.767712 0.367628 0.041*
C5 0.2933 (2) 0.6691 (3) 0.47434 (14) 0.0293 (6)
H5 0.372599 0.638181 0.469100 0.035*
C6 0.2584 (2) 0.6374 (3) 0.54257 (13) 0.0241 (6)
C7 0.3204 (2) 0.5697 (3) 0.61665 (13) 0.0221 (5)
C8 0.4372 (2) 0.5100 (3) 0.64865 (13) 0.0234 (6)
H8 0.497626 0.503812 0.619758 0.028*
C9 0.4620 (2) 0.4600 (3) 0.72446 (13) 0.0215 (5)
C10 0.2671 (2) 0.5224 (3) 0.73927 (13) 0.0214 (5)
C11 0.2353 (2) 0.5765 (3) 0.66288 (13) 0.0214 (5)
C12 0.1810 (2) 0.5238 (3) 0.79032 (13) 0.0214 (5)
C13 0.2208 (2) 0.5743 (3) 0.86635 (13) 0.0258 (6)
H13 0.302957 0.609362 0.885050 0.031*
C14 0.1418 (2) 0.5739 (4) 0.91458 (14) 0.0314 (6)
H14 0.169979 0.608292 0.966195 0.038*
C15 0.0217 (2) 0.5235 (3) 0.88795 (14) 0.0309 (6)
H15 −0.032702 0.524463 0.921050 0.037*
C16 −0.0187 (2) 0.4717 (3) 0.81268 (14) 0.0294 (6)
H16 −0.100834 0.436256 0.794324 0.035*
C17 0.0601 (2) 0.4715 (3) 0.76440 (14) 0.0260 (6)
H17 0.031772 0.435366 0.713019 0.031*
C18 0.5854 (2) 0.3917 (3) 0.76081 (14) 0.0245 (6)
C19 0.7064 (2) 0.2410 (4) 0.86703 (15) 0.0338 (7)
H19A 0.736619 0.157553 0.833004 0.051*
H19B 0.698172 0.174387 0.912670 0.051*
H19C 0.763623 0.342675 0.881388 0.051*
N1 0.12679 (17) 0.6445 (3) 0.62153 (11) 0.0250 (5)
H1 0.060068 0.659505 0.638212 0.030*
N2 0.38040 (17) 0.4664 (3) 0.76895 (11) 0.0227 (5)
O1 0.67253 (15) 0.4035 (3) 0.73280 (10) 0.0345 (5)
O2 0.58916 (14) 0.3127 (2) 0.82863 (9) 0.0264 (4)

1 Source of materials

To a solution of 3-chloro-1-phenyl-9H-pyrido[3,4-b]indole (2.78 g, 10 mmol) in methanol (25 mL) were added 1,1′-bis(diphenylphosphino)ferrocene-palladium(II) dichloride dichloromethane complex (408 mg, 0.5 mmol) and triethylamine (3.0 g, 30 mmol). Then, carbon monoxide gas (5 atm) was introduced into the reaction system and stirred at 60 °C for 3 h, until the TLC indicated the reaction was completed. The solvent was evaporated using a rotary evaporator, yielding the crude product that was purified. For crystal growth, the crude product was dissolved in a minimal amount of hot methanol and slowly cooled to room temperature.

2 Experimental details

Hydrogen atoms were assigned isotropic displacement factors: U iso(H) = 1.2 times U eq(C). All hydrogen atoms were refined as being bonded to their respective parent atoms.

3 Comment

Pyrido[3,4-b]indoles, which consist of a fused indole ring with a pyridine component, have been discovered to disrupt DNA replication and transcription, evoke strong neuropharmacological effects, and exhibit excellent cytotoxicity against cancer cells, fungi, and bacteria. 5 Numerous crystal structures of pyrido[3,4-b]indole derivatives have been reported in the literature. 6 , 7 , 8 , 9 , 10 , 11 , 12 In this paper, we report a crystal structure of a pyrido[3,4-b]indole derivative and provide a detailed discussion, thereby offering a foundation for drug development based on the reported crystal structure.

In the crystal structure of the titled compound, the skeleton atoms of the pyrido[3,4-b]indole moiety are almost coplanar, forming a conjugated structure consistent with many previously reported crystal structures of pyrido[3,4-b]indole derivatives. 13 , 14 , 15 , 16 , 17 , 18 , 19 Additionally, the atoms in the aliphatic group within this crystal structure are also nearly coplanar with the skeleton atoms of the pyrido[3,4-b]indole moiety, with the dihedral angle C8–C9–C18–O1 being only 12.5(4)°. The benzene ring in the crystal structure is significantly twisted relative to the pyrido[3,4-b]indole moiety, with a dihedral angle of 39.5°. Furthermore, no significant intermolecular hydrogen bonds were observed in the crystal structure.

Corresponding author: Bin Liu, Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy, Shaanxi Institute of International Trade & Commerce, Xianyang, Shaanxi, China, E-mail:

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Natural Science Foundation of Shannxi Province (2024JC–YBMS-733), Scientific research plan project of Shaanxi Provincial Department of Education (23JK0321), the Xianyang key laboratory of molecular imaging and drug synthesis (2021QXNL–PT-0008), the 2023 key research and development project of the Xianyang Science and Technology Bureau (L2023–ZDYF–SF-030).

  3. Conflict of interest: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar

2. Sheldrick, G. M. SHELXT – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8. https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8. https://doi.org/10.1107/s2053229614024218.Search in Google Scholar PubMed PubMed Central

4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341. https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

5. Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles Among U. S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014, 57, 10257–10274. https://doi.org/10.1021/jm501100b.Search in Google Scholar PubMed

6. Yu, G.; Li, Y.-Z.; Cao, L.-Y.; Zhang, X.-M.; Wang, K.; Hu, H.-W. 1-Ethyl-2-Oxo-5-Phenyl-1,6-Dihydro-2H-Oxazolo[4′,5′:5,6]Pyrido[3,4-b]Indole Methanol Hemisolvate. Acta Crystallogr. 2004, E60, o1271–o1272. https://doi.org/10.1107/s1600536804015193.Search in Google Scholar

7. Leboeuf, M.; Cavé, A.; Forgacs, P.; Provost, J.; Chiaroni, A.; Riche, C. Alkaloids of the Annonaceae. Part 33. Annomontine and Methoxyannomontine, Two New Pyrimidine-β-Carboline-Type Alkaloids from Annona montana. J. Chem. Soc., Perkin Trans. 1982, 1, 1205–1208. https://doi.org/10.1039/p19820001205.Search in Google Scholar

8. Yokomori, Y.; Sekido, K.; Wu, T.-S.; Tien, H.-J.; Hirokawa, S. The Crystal and Molecular Structure of 1-(2-Amino-4-Pyrimidinyl)-β-Carboline. Bull. Chem. Soc. Jpn. 2006, 55, 2236–2238. https://doi.org/10.1246/bcsj.55.2236.Search in Google Scholar

9. He, L.; Li, Y.; Tan, C.-P.; Ye, R.-R.; Chen, M.-H.; Cao, J.-J.; Ji, L.-N.; Mao, Z.-W. Cyclometalated Iridium(iii) Complexes as Lysosome-Targeted Photodynamic Anticancer and Real-Time Tracking Agents. Chem. Sci. 2015, 6, 5409–5418. https://doi.org/10.1039/c5sc01955a.Search in Google Scholar PubMed PubMed Central

10. Huang, Y.-Q.; Song, H.-J.; Liu, Y.-X.; Wang, Q.-M. Dehydrogenation of N-Heterocycles by Superoxide Ion Generated Through Single-Electron Transfer. Chem. Eur. J. 2018, 24, 2065–2069. https://doi.org/10.1002/chem.201705202.Search in Google Scholar PubMed

11. Dai, J.; Dan, W.; Ren, S.; Shang, C.; Wang, J. Design, Synthesis and Biological Evaluations of Quaternization Harman Analogues as Potential Antibacterial Agents. Eur. J. Med. Chem. 2018, 160, 23–36. https://doi.org/10.1016/j.ejmech.2018.10.012.Search in Google Scholar PubMed

12. Wang, Z.-X.; Xiang, J.-C.; Cheng, Y.; Ma, J.-T.; Wu, Y.-D.; Wu, A.-X. Direct Biomimetic Synthesis of β-Carboline Alkaloids from Two Amino Acids. J. Org. Chem. 2018, 83, 12247–12254. https://doi.org/10.1021/acs.joc.8b01668.Search in Google Scholar PubMed

13. Sheng, T.; Kong, M.; Wang, Y.; Wu, H.; Gu, Q.; Chuang, A. S.; Li, S.; Gao, X. Discovery and Preliminary Mechanism of 1-Carbamoyl β-Carbolines as New Antifungal Candidates. Eur. J. Med. Chem. 2021, 222, 113563. https://doi.org/10.1016/j.ejmech.2021.113563.Search in Google Scholar PubMed

14. Zhang, H.; Zhang, R.-H.; Liao, X.-M.; Yang, D.; Wang, Y.-C.; Zhao, Y.-L.; Xu, G.-B.; Liu, C.-H.; Li, Y.-J.; Liao, S.-G.; Zhou, M. Discovery of β-Carboline Derivatives as a Highly Potent Cardioprotectant Against Myocardial Ischemia-Reperfusion Injury. J. Med. Chem. 2021, 64, 9166–9181. https://doi.org/10.1021/acs.jmedchem.1c00384.Search in Google Scholar PubMed

15. Letessier, J.; Detert, H.; Götz, K.; Opatz, T. Microwave-Assisted Synthesis of 1,3-Disubstituted β-Carbolines from α-(Alkylideneamino)Nitriles and Gramine. Synthesis 2012, 44, 747–754. https://doi.org/10.1055/s-0031-1289675.Search in Google Scholar

16. Sang, J.; Feng, L.; Hu, R.; Chen, J.; Shang, D.; Bao, Q.; Rao, W. Sc(OTf) 3-Catalyzed C2-Selective Cyanation/Defluorination Cascade of Perfluoroalkylated 3-Indolylmethanols and Application to the Synthesis of 3-Fluoro(Perfluoroalkyl)-β-Carbolines. Org. Lett. 2021, 23, 7666–7671. https://doi.org/10.1021/acs.orglett.1c02932.Search in Google Scholar PubMed

17. Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J. Synthesis and Evaluation of β-Carboline Derivatives as Potential Monoamine Oxidase Inhibitors. Bioorg. Med. Chem. 2011, 19, 134–144. https://doi.org/10.1016/j.bmc.2010.11.041.Search in Google Scholar PubMed

18. Pal, B.; Jaisankar, P.; Sesha Giri, V.; Mondal, S.; Mukherjee, M. Unusual Formation of β-Carboline Dimers Under Bischler–Napieralski Reaction Conditions: An Old Reaction with a New Direction. Tetrahedron Lett. 2004, 45, 6489–6492. https://doi.org/10.1016/j.tetlet.2004.06.118.Search in Google Scholar

19. Kusurkar, R. S.; Alkobati, N. A. H.; Gokule, A. S.; Puranik, V. G. Use of the Pictet–Spengler Reaction for the Synthesis of 1,4-Disubstituted-1,2,3,4-Tetrahydro-β-Carbolines and 1,4-Disubstituted-β-Carbolines: Formation of γ-Carbolines. Tetrahedron 2008, 64, 1654–1662. https://doi.org/10.1016/j.tet.2007.12.008.Search in Google Scholar
Received: 2024-07-28
Accepted: 2024-09-17
Published Online: 2024-09-30
Published in Print: 2024-12-17

© 2024 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 3-nitrophenol-2,1,3-benzoselenadiazole (1/1), C12H9N3O3Se
  4. Crystal structure of diaqua-(hydroxido)-{μ-[2-(hydroxy)-5-[(4-nitrophenyl)diazenyl]benzoato]}-{2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoato}-(1,10-phenanthroline)-diterbium hydrate, C38H27.4N8O12.2Tb
  5. Crystal structure of poly[bis(μ3-3-fluoro-4-(1H-1,2,4-triazol-1-yl)benzoato-κ3 O:O′:N)cadmium(II)] – dimethylformamide (1/1), C21H17CdF2N7O5
  6. The crystal structure of 2-amino-N-(pyridin-2-yl)benzamide, C12H11N3O
  7. The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1H)-one, C18H14N4O
  8. Crystal structure of 2-chloro-4-fluorobenzyl (R)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18ClFO3
  9. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
  10. The crystal structure of 2-ethyl-1,1-dimethyl-1H-benzo[e]indole, C16H17N
  11. The crystal structure of (Z)-5-amino-N ′-hydroxy-1H-pyrazole-4-carboximidamide, C4H7N5O
  12. The crystal structure of 2,2,5-trimethyl-3-(4-(4-(5-phenyl-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)phenyl)imidazolidin-4-one, C24H24N4O2S
  13. The crystal structure of tetrakis(μ2-acetato-κ2 O:O′)-bis[(4′-phenyl-4,2′:6′,4″-terpyridine-κ1 N)dicopper(II)], C25H21CuN3O4
  14. Crystal structure of poly(3-thiophenecarboxylato-κ 3 O,O′:O′)-(methanol-κO)cadmium(II), C11H10O5S2Cd
  15. The crystal structure of dichloridobis[4′-(p-methoxylphenyl)-4,2′:6′,4″-terpyridine-κN] zinc(II), C44H34Cl2N6O2Zn
  16. The crystal structure of 1-(2-carboxyethyl)-1H-imidazole 3-oxide
  17. Crystal structure of 1,1′,1″-(nitrilotris(ethane-2,1-diyl))tris(3-(4-(((E)-pyridin-2-ylmethylene)amino)phenyl)urea), C45H47N13O4
  18. Crystal structure of a (E)-4-bromo-N-(4-(diethylamino)-2-hydroxybenzylidene) benzenaminium acetate ─ 4-bromoaniline (1/1)
  19. Crystal structure of 2,2′-(iminobis(methylene))bis(benzimidazolium) bis(p-toluenesulfonate), C30H31N5O6S2
  20. The crystal structure of alogliptinium meta-chlorobenzoate
  21. Crystal structure of 4-bromobenzyl 2-(6-methoxy-naphthalen-2-yl)propanoate, C21H19BrO3
  22. The hydrated double salt structure of (E)-4-(2-benzylidenehydrazine-1-carbonyl)pyridin-1-ium cation with 2-hydroxybenzoate and benzoate anions
  23. Crystal structure of (R)(R)-5-chloro-3-((S,1E,3E)-3,5-dimethyl-hepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinolin-7-yl acetate, C21H24ClNO4
  24. The crystal structure of bis(3-oxo-1,3-diphenylprop-1-en-1-olato-κ 2 O:O′)-bis(1,4-dioxane-κ 1 O)nickel(II), C38H38O8Ni
  25. Crystal structure of poly[aqua-(pyridine-3-carboxylato-κ1 N)(pyridine-3-carboxylato-κ2 O,O′) cadmium(II)] dihydrate, C12H14N2O7Cd
  26. The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-1,2,4-triazol-3-yl)pyridine, C22H14Br3N7S
  27. The crystal structure of N-benzylquinoline-2-carbothioamide, C17H14N2S
  28. Crystal structure of bis(3-isopropylphenyl)-4,4′-bipyridinium dichloride dihydrate, C28H30N2⋅2Cl⋅2H2O
  29. The crystal structure of ethyl 2-amino-4-(cyanophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C19H18N2O4
  30. Crystal structure of (4R,10S)-6-hydroxy-7-isopropyl-4,10-dimethyl-1,2,3,5-hexahydro-6,10-epoxyazulen-9-one, C15H22O3
  31. The crystal structure of (E)-(2-(2-hydroxy-3-methoxybenzylidene)aminophenyl)arsonic acid, C14H14AsNO5
  32. The crystal structure of poly[(μ 2-2-aminoisophthalato-κ4O,O′:O″:O″′)-(N-methylpyrrolidone κ1O)-dioxido-uranium(VI)], C13H14N2O7U
  33. The crystal structure of the co-crystal isonicotinamide · terephthalic acid, C8H6O4·2(C6H6N2O)
  34. The crystal structure of (E)-1-phenyl-3-(p-tolylthio)but-2-en-1-one, C17H16OS
  35. The crystal structure of 4,5-bis((Z)-chloro(hydroxyimino)methyl)-1H-imidazol-3-ium chloride monohydrate
  36. The crystal structure of 1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-dione. C18H20N2O2
  37. Crystal structure of 2-chloro-4-fluorobenzyl 2-acetoxybenzoate, C16H12ClFO4
  38. Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
  39. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4
  40. Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
  41. Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxalin-1-yl)anilin, C30H24N4O2
  42. Crystal structure of 5,7-dihydroxy-2-phenyl-4H-chromen-4-one–N,N-dimethylformamide(1/1), C18H17NO5
  43. The crystal structure of bis(μ 2-biphenyl-2,2′-dicarboxylato)-diaqua-bis(nitrato)-bis(2,2′:6′,2′′-terpyridine)dineodymium(III), C46H32I2N8Nd2O16
  44. Crystal structure of (Z)-4-amino-N ′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O
  45. Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
  46. Crystal structure of (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl) methyl)-4-fluorobenzonitrile benzoate monohydrate, C24H27FN6O4
  47. The crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylato-κ 3 N,O,O)copper(II)]monohydrate, C12H15NO9Cu
  48. Crystal structure of (((4-chlorophenyl)sulfonyl)glycinato-κ 2 N,O)bis(1,10-phenanthroline-κ 2 N,N′)cobalt(II) tetrahydrate, C32H30ClCoN5O8S
  49. Crystal structure of (((3-nitrophenyl)sulfonyl)-β-alaninato-κO)bis(2,2′-bipyridine-κ 2 N, N′)copper(II) 3-nitrobenzenesulfonate, C35H29CuN7O11S2
  50. Crystal structure of 3-phenoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C27H24O4
  51. 6-(2′,3′-Dihydroxy-3′-methylbutyl)-7-methoxy-8-(3″-methylbut-2″-en-1″-yl)-2H-chromen-2-one, C20H26O5
  52. Crystal structure of bromido-(2,2′:6′,2″-terpyridine-4′-onato-κ3N)palladium(II) methanol solvate
  53. The crystal structure of ethyl 2-amino-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H22N2O6
  54. Crystal structure of (1E,3E,5E)-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C28H36O2
  55. The crystal structure of tris(2-bromo-4-methylphenyl)amine, C21H18Br3N
  56. The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1H-pyrrole-2,5-dione, C21H22N2O2
  57. Crystal structure of dicarbonyl (μ2-indole-2-carboxylato κ2 O:O′)tris(triphenylarsine-κAs)dirhodium(I) acetone solvate, C68H56As3NO5Rh2
  58. The crystal structure of 4-chloro-2-formylphenyl 4-methylbenzenesulfonate, C14H11ClO4S
  59. Crystal structure of 4-iodobenzyl 2-(6-methoxynaphthalen-2-yl) propanoate, C21H19IO3
https://doi.org/10.1515/ncrs-2024-0320
Creative Commons
BY 4.0

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of 3-nitrophenol-2,1,3-benzoselenadiazole (1/1), C12H9N3O3Se
  4. Crystal structure of diaqua-(hydroxido)-{μ-[2-(hydroxy)-5-[(4-nitrophenyl)diazenyl]benzoato]}-{2-hydroxy-5-[(4-nitrophenyl)diazenyl]benzoato}-(1,10-phenanthroline)-diterbium hydrate, C38H27.4N8O12.2Tb
  5. Crystal structure of poly[bis(μ3-3-fluoro-4-(1H-1,2,4-triazol-1-yl)benzoato-κ3 O:O′:N)cadmium(II)] – dimethylformamide (1/1), C21H17CdF2N7O5
  6. The crystal structure of 2-amino-N-(pyridin-2-yl)benzamide, C12H11N3O
  7. The crystal structure of 2,3-di(pyridin-2-yl)-2,3-dihydroquinazolin-4(1H)-one, C18H14N4O
  8. Crystal structure of 2-chloro-4-fluorobenzyl (R)-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18ClFO3
  9. Crystal structure of [1-(4-carboxyphenyl)-4-oxo-1,4-dihydropyridazine-3-carboxylic acid]-(methylsulfinyl)methane, C15H16N2O6S
  10. The crystal structure of 2-ethyl-1,1-dimethyl-1H-benzo[e]indole, C16H17N
  11. The crystal structure of (Z)-5-amino-N ′-hydroxy-1H-pyrazole-4-carboximidamide, C4H7N5O
  12. The crystal structure of 2,2,5-trimethyl-3-(4-(4-(5-phenyl-4,5-dihydroisoxazol-3-yl)thiazol-2-yl)phenyl)imidazolidin-4-one, C24H24N4O2S
  13. The crystal structure of tetrakis(μ2-acetato-κ2 O:O′)-bis[(4′-phenyl-4,2′:6′,4″-terpyridine-κ1 N)dicopper(II)], C25H21CuN3O4
  14. Crystal structure of poly(3-thiophenecarboxylato-κ 3 O,O′:O′)-(methanol-κO)cadmium(II), C11H10O5S2Cd
  15. The crystal structure of dichloridobis[4′-(p-methoxylphenyl)-4,2′:6′,4″-terpyridine-κN] zinc(II), C44H34Cl2N6O2Zn
  16. The crystal structure of 1-(2-carboxyethyl)-1H-imidazole 3-oxide
  17. Crystal structure of 1,1′,1″-(nitrilotris(ethane-2,1-diyl))tris(3-(4-(((E)-pyridin-2-ylmethylene)amino)phenyl)urea), C45H47N13O4
  18. Crystal structure of a (E)-4-bromo-N-(4-(diethylamino)-2-hydroxybenzylidene) benzenaminium acetate ─ 4-bromoaniline (1/1)
  19. Crystal structure of 2,2′-(iminobis(methylene))bis(benzimidazolium) bis(p-toluenesulfonate), C30H31N5O6S2
  20. The crystal structure of alogliptinium meta-chlorobenzoate
  21. Crystal structure of 4-bromobenzyl 2-(6-methoxy-naphthalen-2-yl)propanoate, C21H19BrO3
  22. The hydrated double salt structure of (E)-4-(2-benzylidenehydrazine-1-carbonyl)pyridin-1-ium cation with 2-hydroxybenzoate and benzoate anions
  23. Crystal structure of (R)(R)-5-chloro-3-((S,1E,3E)-3,5-dimethyl-hepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinolin-7-yl acetate, C21H24ClNO4
  24. The crystal structure of bis(3-oxo-1,3-diphenylprop-1-en-1-olato-κ 2 O:O′)-bis(1,4-dioxane-κ 1 O)nickel(II), C38H38O8Ni
  25. Crystal structure of poly[aqua-(pyridine-3-carboxylato-κ1 N)(pyridine-3-carboxylato-κ2 O,O′) cadmium(II)] dihydrate, C12H14N2O7Cd
  26. The crystal structure of 4-(4-phenyl-5-(((1-(2,4,6-tribromophenyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-4H-1,2,4-triazol-3-yl)pyridine, C22H14Br3N7S
  27. The crystal structure of N-benzylquinoline-2-carbothioamide, C17H14N2S
  28. Crystal structure of bis(3-isopropylphenyl)-4,4′-bipyridinium dichloride dihydrate, C28H30N2⋅2Cl⋅2H2O
  29. The crystal structure of ethyl 2-amino-4-(cyanophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C19H18N2O4
  30. Crystal structure of (4R,10S)-6-hydroxy-7-isopropyl-4,10-dimethyl-1,2,3,5-hexahydro-6,10-epoxyazulen-9-one, C15H22O3
  31. The crystal structure of (E)-(2-(2-hydroxy-3-methoxybenzylidene)aminophenyl)arsonic acid, C14H14AsNO5
  32. The crystal structure of poly[(μ 2-2-aminoisophthalato-κ4O,O′:O″:O″′)-(N-methylpyrrolidone κ1O)-dioxido-uranium(VI)], C13H14N2O7U
  33. The crystal structure of the co-crystal isonicotinamide · terephthalic acid, C8H6O4·2(C6H6N2O)
  34. The crystal structure of (E)-1-phenyl-3-(p-tolylthio)but-2-en-1-one, C17H16OS
  35. The crystal structure of 4,5-bis((Z)-chloro(hydroxyimino)methyl)-1H-imidazol-3-ium chloride monohydrate
  36. The crystal structure of 1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-dione. C18H20N2O2
  37. Crystal structure of 2-chloro-4-fluorobenzyl 2-acetoxybenzoate, C16H12ClFO4
  38. Crystal structure of methyl 1-phenyl-9H-pyrido[3,4-b]indole-3-carboxylate, C19H14N2O2
  39. Crystal structure of (3-(dimethoxymethyl)-5-methoxy-1H-indol-1-yl)(5-fluoro-2-iodophenyl)methanone, C19H17FINO4
  40. Crystal structure of tetrachlorido-bis(1-[(1H-triazole-1-yl)methyl]-1H-benzotriazole-κ2 N:N′)dicopper, C36H32Cu2N24Cl4
  41. Crystal structure of 2-(2,3-bis(4-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxalin-1-yl)anilin, C30H24N4O2
  42. Crystal structure of 5,7-dihydroxy-2-phenyl-4H-chromen-4-one–N,N-dimethylformamide(1/1), C18H17NO5
  43. The crystal structure of bis(μ 2-biphenyl-2,2′-dicarboxylato)-diaqua-bis(nitrato)-bis(2,2′:6′,2′′-terpyridine)dineodymium(III), C46H32I2N8Nd2O16
  44. Crystal structure of (Z)-4-amino-N ′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O
  45. Crystal structure of (E)-6,8-dimethoxy-4-(4-morpholinobenzylidene)-3,4-dihydro-1-benzoxepin-5(2H)-one, C23H25NO5
  46. Crystal structure of (R)-2-((3-(3-aminopiperidin-1-yl)-6-methyl-5-oxo-1,2,4-triazin-4(5H)-yl) methyl)-4-fluorobenzonitrile benzoate monohydrate, C24H27FN6O4
  47. The crystal structure of [triaqua-(8-carboxymethoxy-quinoline-2-carboxylato-κ 3 N,O,O)copper(II)]monohydrate, C12H15NO9Cu
  48. Crystal structure of (((4-chlorophenyl)sulfonyl)glycinato-κ 2 N,O)bis(1,10-phenanthroline-κ 2 N,N′)cobalt(II) tetrahydrate, C32H30ClCoN5O8S
  49. Crystal structure of (((3-nitrophenyl)sulfonyl)-β-alaninato-κO)bis(2,2′-bipyridine-κ 2 N, N′)copper(II) 3-nitrobenzenesulfonate, C35H29CuN7O11S2
  50. Crystal structure of 3-phenoxybenzyl 2-(6-methoxynaphthalen-2-yl)propanoate, C27H24O4
  51. 6-(2′,3′-Dihydroxy-3′-methylbutyl)-7-methoxy-8-(3″-methylbut-2″-en-1″-yl)-2H-chromen-2-one, C20H26O5
  52. Crystal structure of bromido-(2,2′:6′,2″-terpyridine-4′-onato-κ3N)palladium(II) methanol solvate
  53. The crystal structure of ethyl 2-amino-(4-nitrophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate, C20H22N2O6
  54. Crystal structure of (1E,3E,5E)-1,6-bis(4-(pentyloxy)phenyl)hexa-1,3,5-triene, C28H36O2
  55. The crystal structure of tris(2-bromo-4-methylphenyl)amine, C21H18Br3N
  56. The crystal structure of 3-(2,5-dimethylanilino)-1-(2,5-dimethylphenyl)-4-methyl-1H-pyrrole-2,5-dione, C21H22N2O2
  57. Crystal structure of dicarbonyl (μ2-indole-2-carboxylato κ2 O:O′)tris(triphenylarsine-κAs)dirhodium(I) acetone solvate, C68H56As3NO5Rh2
  58. The crystal structure of 4-chloro-2-formylphenyl 4-methylbenzenesulfonate, C14H11ClO4S
  59. Crystal structure of 4-iodobenzyl 2-(6-methoxynaphthalen-2-yl) propanoate, C21H19IO3
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2024-0320/html?lang=en
Scroll to top button